Skip to content

DRMAW

Dermata Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.00
−50.00%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 18, 2026
EPS estimate
-$0.55
Revenue estimate
$25.0K

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.74
EPS estimate
-$0.55
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
+12.1%
Revenue beats (12Q)
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.55-$0.74Miss -34.55%
May 13, 2026-$0.53-$0.48Beat 9.43%
Mar 26, 2026-$1.54-$0.35Beat 77.27%
Nov 14, 2025-$1.59-$1.65Miss -3.67%
Aug 13, 2025-$2.90-$1.66Beat 42.86%
May 14, 2025-$4.50-$0.45Beat 90.07%
Sep 29, 2023-$0.54

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026